Skip to main content
Log in

Myopie in Deutschland – Veränderungen der Prävalenz bleiben unklar

Myopia in Germany—changes in the prevalence remain unclear

  • Leserbriefe
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

A Leserbriefe to this article was published on 22 May 2019

The Original Article was published on 06 November 2017

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Jobke S, Kasten E, Vorwerk C (2008) The prevalence rates of refractive errors among children, adolescents, and adults in Germany. Clin Ophthalmol 2:601–607

    Article  Google Scholar 

  2. Klüsener S, Grigoriev P, Scholz RD et al (2018) Adjusting Inter-censal Population Estimates for Germany 1987–2011: Approaches and Impact on Demographic Indicators. Comp Popul Stud 43:31–64

    Google Scholar 

  3. Schuster AK, Elflein HM, Pokora R et al (2017) Prevalence and risk factors of myopia in children and adolescents in Germany—results of the KiGGS survey. Klin Padiatr 229:234–240

    Article  Google Scholar 

  4. Wesemann W (2018) Analysis of spectacle lens prescriptions shows no increase of myopia in Germany from 2000 to 2015. Ophthalmologe 115:409–417

    Article  CAS  Google Scholar 

  5. Wesemann W (2018) Prevalence of spectacle wearers in Germany: clear increase from 1952–2014. Ophthalmologe 115:421–423

    Article  CAS  Google Scholar 

  6. Ziemssen F (2018) No increase in myopia? Ophthalmologe 115:418–421

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander K. Schuster.

Ethics declarations

Interessenkonflikt

R.P. Finger weist auf folgende Beziehungen hin: Beratung/Honorare von Bayer, Novartis, Ellex, Santen, Santhera, RetinaImplant, Alimera, Inositec, Opthea; Unterstützung von Forschungsprojekten durch Novartis, Centrevue, Heidelberg Engineering, Zeiss. A.K. Schuster hat die Stiftungsprofessur für ophthalmologische Versorgungsforschung inne, gestiftet von der Stiftung Auge und finanziert von der Deutschen Ophthalmologischen Gesellschaft und dem Berufsverband der Augenärzte Deutschlands e. V. Er erhält für andere Forschungsprojekte Unterstützung von Bayer Vital, Novartis und Heidelberg Engineering.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Finger, R.P., Schuster, A.K. Myopie in Deutschland – Veränderungen der Prävalenz bleiben unklar. Ophthalmologe 116, 682–683 (2019). https://doi.org/10.1007/s00347-019-0915-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-019-0915-1

Navigation